LUMO - Lumos Pharma GAAP EPS of -$0.89 beats by $0.24 revenue of $0.69M beats by $0.57M May, 03 2023 05:20 PM Lumos Pharma Inc. 2023-05-03 17:20:04 ET Lumos Pharma press release ( NASDAQ: LUMO ): Q1 GAAP EPS of -$0.89 beats by $0.24 . Revenue of $0.69M (+527.3% Y/Y) beats by $0.57M . For further details see: Lumos Pharma GAAP EPS of -$0.89 beats by $0.24, revenue of $0.69M beats by $0.57M